European commercialization

Devices & Diagnostics

Shock absorbers for the human body? Implant could help active patients avoid total knee replacements longer

Think shock absorbers for the human body. Moximed could help active and young patients who have osteoarthritis prolong the amount of time before total knee replacement. The Heyward, Calif.-based company’s Kinespring Knee Implant System is a medical device that absorbs part of the load put on the knee, without changing anatomy. The device is positioned […]

MedCity Influencers

Europe Ups the Post-Market Ante for New Medical Devices

While Europe may still provide a faster route to regulatory approval for such devices, post-market requirements are creeping in like an expensive final cheese course served by European regulators and health systems just when companies are feeling most broke and tired. So regulatory approvals may come, but actual, meaningful revenues? Not so fast.

MedCity Influencers

Six Costly Mistakes to Avoid When Launching Medical Devices in Europe: Practical and Timely Advice for Start-Up CEOs

Representing one-third of the global medical device market, the European Union provides a significant opportunity for start-up, medical device companies. But, it can also present costly challenges for the unprepared. Following are a half-dozen cautions drawn from real-world experience that could help you avoid some common commercial pitfalls. 1. Chasing conflicting commercialization objectives.  What are […]